Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.87M Buy
+150,000
New +$5.57M 0.02% 589
2020
Q3
Sell
-429,481
Closed -$19.5M 599
2020
Q2
$19.5M Buy
+429,481
New +$19.2M 0.49% 36
2019
Q3
Sell
-8,007
Closed -$345K 497
2019
Q2
$345K Buy
+8,007
New +$332K 0.01% 336
2018
Q2
Sell
-6,406
Closed -$214K 565
2018
Q1
$214K Hold
6,406
0.02% 301
2017
Q4
$214K Sell
6,406
-848
-12% -$29.2K 0.02% 301
2017
Q3
$242K Sell
7,254
-843
-10% -$29K 0.03% 253
2017
Q2
$285K Buy
+8,097
New +$273K 0.02% 485

Other funds holding QGEN

LMR Partners's QGEN Position: Q2 2026 in Review

LMR Partners opened a new position in Qiagen (QGEN) in Q2 2026: 150,000 shares worth $5.87M. The stake represents 0.02% of the portfolio and ranks #589 among its holdings. This is a return to the name: LMR Partners previously reported a position in QGEN as recently as Q2 2020.

LMR Partners first reported a position in QGEN in Q2 2017 and has held it in 7 quarters since. The position peaked at $19.5M in Q2 2020. 337 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • LMR Partners held 150,000 shares of Qiagen worth $5.87M as of Q2 2026.
  • Qiagen was a new LMR Partners position in Q2 2026.
  • Qiagen made up 0.02% of LMR Partners's portfolio in Q2 2026, its #589 holding.
  • LMR Partners first reported a position in Qiagen in Q2 2017 and has held it in 7 quarters since.
  • LMR Partners's Qiagen position peaked at $19.5M in Q2 2020.
  • 337 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.